Clearmind Medicine Depreciation & Amortization Growth & History (CMND)

Clearmind Medicine's depreciation and amortization was $49,369 for fiscal 2025.

View full Clearmind Medicine company overview

Clearmind Medicine annual depreciation and amortization history

Clearmind Medicine annual depreciation and amortization

Fiscal yearPeriod endedDepreciation and amortizationChangeGrowth
20252025-10-31$49,369−$638−1.28%
20242024-10-31$50,007$3,672+7.92%
20232023-10-31$46,335$23,933+106.83%
20222022-10-31$22,402$20,516+1087.80%
20212021-10-31$1,886

Clearmind Medicine depreciation and amortization trends

Between the periods ended 2021-10-31 and 2025-10-31, Clearmind Medicine's depreciation and amortization increased from $1,886 to $49,369, a change of $47,483. The latest reported quarter, Q2 2026, shows $13,901.

About the metric

What depreciation and amortization mean

Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.

Calculation and source

Reported depreciation and amortization

TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Clearmind Medicine source filings ↗

Community posts

It’s quiet here.

No posts about CMND yet. Start the conversation.

Write the first post